| Product Code: ETC067228 | Publication Date: Jun 2021 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
1 Executive Summary  | 
2 Introduction  | 
2.1 Key Highlights of the Report  | 
2.2 Report Description  | 
2.3 Market Scope & Segmentation  | 
2.4 Research Methodology  | 
2.5 Assumptions  | 
3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Overview  | 
3.1 United Kingdom (UK) Country Macro Economic Indicators  | 
3.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, 2021 & 2031F  | 
3.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Industry Life Cycle  | 
3.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Porter's Five Forces  | 
3.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Form, 2021 & 2031F  | 
3.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Workflow, 2021 & 2031F  | 
3.7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Therapeutic Application, 2021 & 2031F  | 
3.8 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume Share, By Modality, 2021 & 2031F  | 
4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Dynamics  | 
4.1 Impact Analysis  | 
4.2 Market Drivers  | 
4.2.1 Increasing demand for advanced diagnostic imaging technologies  | 
4.2.2 Technological advancements in artificial intelligence (AI) and machine learning  | 
4.2.3 Rising prevalence of chronic diseases requiring accurate and timely diagnosis  | 
4.3 Market Restraints  | 
4.3.1 High initial investment and ongoing maintenance costs for AI-enabled imaging modalities  | 
4.3.2 Regulatory challenges and data privacy concerns associated with AI in healthcare  | 
5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Trends  | 
6 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Types  | 
6.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Product  | 
6.1.1 Overview and Analysis  | 
6.1.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Product, 2018 - 2027F  | 
6.1.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Software, 2018 - 2027F  | 
6.1.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Hardware, 2018 - 2027F  | 
6.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Workflow  | 
6.2.1 Overview and Analysis  | 
6.2.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Acquisition, 2018 - 2027F  | 
6.2.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Image Analytics, 2018 - 2027F  | 
6.2.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Detection, 2018 - 2027F  | 
6.2.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Reporting & Communication, 2018 - 2027F  | 
6.2.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Diagnosis & Treatment Decision Report, 2018 - 2027F  | 
6.2.7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F  | 
6.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Therapeutic Application  | 
6.3.1 Overview and Analysis  | 
6.3.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Cardiology, 2018 - 2027F  | 
6.3.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Oncology, 2018 - 2027F  | 
6.3.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Respiratory, 2018 - 2027F  | 
6.3.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Orthopedics, 2018 - 2027F  | 
6.3.6 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F  | 
6.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market, By Modality  | 
6.4.1 Overview and Analysis  | 
6.4.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Mammography, 2018 - 2027F  | 
6.4.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By X-ray, 2018 - 2027F  | 
6.4.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Ultrasound, 2018 - 2027F  | 
6.4.5 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenues & Volume, By Others, 2018 - 2027F  | 
7 United Kingdom (UK) AI-Enabled Imaging Modalities Market Import-Export Trade Statistics  | 
7.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Export to Major Countries  | 
7.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Imports from Major Countries  | 
8 United Kingdom (UK) AI-Enabled Imaging Modalities Market Key Performance Indicators  | 
8.1 Adoption rate of AI-enabled imaging modalities in healthcare facilities  | 
8.2 Rate of integration of AI algorithms into existing imaging modalities  | 
8.3 Improvement in diagnostic accuracy and efficiency achieved through AI implementation  | 
9 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Opportunity Assessment  | 
9.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Product, 2021 & 2031F  | 
9.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Workflow, 2021 & 2031F  | 
9.3 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Therapeutic Application, 2021 & 2031F  | 
9.4 United Kingdom (UK) AI-Enabled Imaging Modalities Market Opportunity Assessment, By Modality, 2021 & 2031F  | 
10 United Kingdom (UK) AI-Enabled Imaging Modalities Market - Competitive Landscape  | 
10.1 United Kingdom (UK) AI-Enabled Imaging Modalities Market Revenue Share, By Companies, 2021  | 
10.2 United Kingdom (UK) AI-Enabled Imaging Modalities Market Competitive Benchmarking, By Operating and Technical Parameters  | 
11 Company Profiles  | 
12 Recommendations  | 
13 Disclaimer  |